Literature DB >> 22772884

[Physiotherapy and ergotherapy are indispensable. Concrete prescription of remedies - without recourse].

J-M Engel1.   

Abstract

Physical therapy and occupational therapy are essential for the treatment of inflammatory rheumatic diseases equal in rank to any drug therapy. They have enough evidence and are part of all current guidelines even if mostly not specified. In the German social security system the doctor prescribing physical therapy or occupational therapy has to act according to the different rules and forms as described in the current "Heilmittel Richtlinie" (Remedy directive) effective since July 2011. The multiple formal conditions and requirements of prescriptions are described in detail. Of special interest is that the global diagnosis of rheumatoid arthritis can no longer be used as the reason or justification for the individual prescription but detailed sub-diagnoses, regarding the essential ICF domains of structural damage, functional impairment, activity limitation and participation restriction as well as individual context factors are necessary. Of special interest is the fact that the prescribing doctor is no longer responsible for the formal correctness of prescriptions but the performing therapist, who will not be reimbursed if the prescription shows even minor formal errors. Another important improvement is the newly introduced long-term prescription of physical and occupational therapy. This facilitates the application of these therapies in the multimodal treatment regimen of rheumatic diseases.

Entities:  

Mesh:

Year:  2012        PMID: 22772884     DOI: 10.1007/s00393-011-0865-8

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  4 in total

Review 1.  [Evidence-based physiotherapeutic strategies for musculoskeletal pain].

Authors:  U Lange; U Müller-Ladner
Journal:  Z Rheumatol       Date:  2008-12       Impact factor: 1.372

Review 2.  [Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis].

Authors:  J R Kalden; H Burkhardt; B Buss; U Donhauser-Gruber; U Erstling; E Gromnica-Ihle; K Karberg; T Karger; C H Kneitz; A Krause; K Krüger; H-M Lorenz; U Müller-Ladner; A Rubbert-Roth; P Steffens-Korbanka; H-P Tony; J Wendler; J Wollenhaupt; G Burmester
Journal:  Z Rheumatol       Date:  2011-10       Impact factor: 1.372

3.  [Deficits of routine occupational therapy services in rheumatic diseases: results of the RheumaDat study].

Authors:  H Thieme; K Löffler; B Borgetto
Journal:  Z Rheumatol       Date:  2010-07       Impact factor: 1.372

4.  [Rehabilitation and outpatient physiotherapy in rheumatic disease patients. Results of cross-sectional studies of patients with rheumatoid arthritis or ankylosing spondylitis and rheumatologists].

Authors:  W Mau; A Müller
Journal:  Z Rheumatol       Date:  2008-11       Impact factor: 1.372

  4 in total
  4 in total

1.  [Trends in rehabilitation of patients with rheumatic diseases in Germany].

Authors:  W Mau; W Beyer; I Ehlebracht-König; J-M Engel; E Genth; W H Jäckel; U Lange; K Thiele
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

2.  [Preservation of ability to work and securing vocational participation : non-pharmaceutical support options for rheumatologists].

Authors:  Y Drambyan; K Parthier
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

3.  [New developments in sociomedical consequences and rehabilitative interventions].

Authors:  W Mau
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

4.  [Social participation and activities of daily living of patients with inflammatory rheumatic diseases : support by self-help, exercise therapy and new media].

Authors:  K Mattukat; A Thyrolf
Journal:  Z Rheumatol       Date:  2014-02       Impact factor: 1.372

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.